Voice-assisted Devices May Help Patients to Speak More Clearly
People with Parkinson’s disease who use voice-assisted technologies (VATs) — software programs that respond to voice commands, like Amazon’s…
Articles by Marisa Wexler, MS
Stem Cell Therapy Shows Safety, Possible Efficacy in Early Trial
Treatment with ISC-hpNSC, an investigational stem cell therapy for Parkinson’s disease, was safe and well-tolerated over at least two years…
Differences in Mouse, Human Astrocytes May Impact Research
Brain cells called astrocytes behave differently under stressful conditions in humans as compared with mice, new research suggests. Because…
Many Who Start Antipsychotics Discontinue Treatment
More than a third of people with Parkinson’s disease who are prescribed antipsychotics stop treatment within six months of…
Jaw Exercises, Oral Hygiene Advice Aids Life Quality in Later Parkinson’s
A program of jaw-related exercises, coupled with individualized advice for oral hygiene, can improve quality of life as it relates…
Low Levels of Some Fatty Acids Found in Parkinson’s Patients
People with Parkinson’s disease have lower-than-normal levels of certain fatty acids in their blood, which is not explained by…
MJFF Offering Online Guide for Patients Considering DBS
The Michael J. Fox Foundation (MJFF) has released a new guide that aims to help people with Parkinson’s disease…
Targeting Mitochondrial DNA May Be Therapeutic Strategy
In Parkinson’s disease, DNA that leaks out of mitochondria — small organelles that generate energy — leads to cell death…
FDA Rejects Verily’s Smartwatch for Parkinson’s Assessment
The U.S. Food and Drug Administration (FDA) has rejected an application from Verily Life Sciences that sought to add…
Phase 1 Trials of Bayer’s Cell and Gene Therapies Enrolling Patients
The first patient has been dosed in a still-recruiting Phase 1 clinical trial testing DA01, an investigational cell therapy for…